Ma Changqing, Quesnelle Kelly M, Sparano Anthony, Rao Shilpa, Park Min S, Cohen Marc A, Wang Yan, Samanta Minu, Kumar Madhu S, Aziz M Usman, Naylor Tara L, Weber Barbara L, Fakharzadeh Steven S, Weinstein Gregory S, Vachani Anil, Feldman Michael D, Brose Marcia S
Department of Otorhinolaryngology, Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA 19104 , USA.
Cancer Biol Ther. 2009 May;8(10):907-16. doi: 10.4161/cbt.8.10.8132. Epub 2009 May 9.
The Cub and Sushi Multiple Domains-1 (CSMD1) is a tumor suppressor gene on 8p23.2, where allelic loss is both frequent and associated with poor prognosis in head and neck squamous cell carcinoma (HNSCC). To understand the extent of CSMD1 aberrations in vivo, we characterized 184 primary tumors from the head and neck, lung, breast and skin for gene copy number and analyzed expression in our HNSCCs and lung squamous cell carcinomas (SCCs). We detected loss of CSMD1 in a large proportion of HNSCCs (50%), lung (46%) and breast cancers (55%), and to a lesser extent in cutaneous SCCs (29%) and basal cell carcinomas (BCCs, 17%) using array-based comparative genomic hybridization (aCGH). Studying the region more closely with quantitative real-time PCR (qPCR), the loss of CSMD1 increased to 80% in HNSCCs and 93% in lung SCCs. CSMD1 expression was decreased in tumors compared to adjacent benign tissue (65%, 13/20) and was likely due to gene loss in 45% of cases (9/20). We also identified truncated transcripts lacking exons due to DNA copy number loss (30%, 5/17) or aberrant splicing (24%, 4/17). We show loss of CSMD1 in primary HNSCC tissues, and document for the first time that CSMD1 is lost in breast, lung and cutaneous SCCs. We also show that deletions of CSMD1 and aberrant splicing contribute to altered CSMD1 function in vivo.
Cub与寿司多结构域蛋白1(CSMD1)是位于8p23.2的一种肿瘤抑制基因,在头颈部鳞状细胞癌(HNSCC)中,该基因座的等位基因缺失很常见且与预后不良相关。为了解CSMD1在体内的畸变程度,我们对184例来自头颈部、肺、乳腺和皮肤的原发性肿瘤进行了基因拷贝数特征分析,并分析了其在我们的HNSCC和肺鳞状细胞癌(SCC)中的表达情况。我们使用基于芯片的比较基因组杂交(aCGH)检测到,在大部分HNSCC(50%)、肺癌(46%)和乳腺癌(55%)中存在CSMD1缺失,而在皮肤SCC(29%)和基底细胞癌(BCC,17%)中缺失程度较小。通过定量实时PCR(qPCR)更仔细地研究该区域,CSMD1在HNSCC中的缺失率增加到80%,在肺SCC中增加到93%。与相邻良性组织相比,肿瘤中CSMD1表达降低(65%,13/20),45%的病例(9/20)可能是由于基因缺失所致。我们还鉴定出因DNA拷贝数缺失(30%,5/17)或异常剪接(24%,4/17)而缺少外显子的截短转录本。我们展示了原发性HNSCC组织中CSMD1的缺失,并首次证明CSMD1在乳腺癌、肺癌和皮肤SCC中也存在缺失。我们还表明,CSMD1的缺失和异常剪接会导致其在体内功能改变。